10 recruiting, 5 completed, 5 not yet recruiting, 1 enrolling by invitation. 7 Phase 1, 6 Phase 2, 4 Not applicable, 1 Early Phase 1, 1 Phase 3.
Follow Systemic Lupus Erthematosus: new trials by email Literature Review of Systemic Lupus Erthematosus trials Research Report on Systemic Lupus Erthematosus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus Personalized Home-Based High-Intensity Interval Training - Systemic Lupus Erthematosus, Fatigue | Not applicable | Not yet recruiting | University of Alabama at Birmingham | 20 | 2026-12-01 | 2026-10-13 |
| Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases anti-CD19 CAR-T cells - Systemic Lupus Erthematosus, Systemic Sclerosis (SSc) | Phase 1 / Phase 2 | Not yet recruiting | Peking University Third Hospital | 9 | 2026-11-01 | 2026-09-23 |
| Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus Ivarmacitinib Sulfate Tablets, Prednisone Acetate Tablets - Systemic Lupus Erthematosus | Phase 2 / Phase 3 | Not yet recruiting | Chinese SLE Treatment And Research Group | 294 | 2026-10-15 | 2026-09-11 |
| Gyrotonic Exercise in Lupus Adolescents Who Survived From Intensive Care Gryotonic exercise - Systemic Lupus Erthematosus, Childhood-onset Systemic Lupus Erythematous | Not applicable | Recruiting | Cairo University | 40 | 2026-08-11 | 2026-09-22 |
| A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) Budoprutug - Systemic Lupus Erthematosus | Phase 1 / Phase 2 | Recruiting | Climb Bio, Inc. | 30 | 2026-06-30 | 2026-10-20 |
| Inducible Co-stimulator Gene With Systemic Lupus Erythematosus Systemic Lupus Erthematosus | Not yet recruiting | South Valley University | 30 | 2026-06-01 | 2026-06-30 | |
| A Study of GR1803 in Systemic Lupus Erythematosus GR1803 injection - Systemic Lupus Erthematosus, Auto Immune Disease | Phase 1 / Phase 2 | Recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 44 | 2026-02-02 | 2026-03-10 |
| Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus Land-based Liuzijue exercise, Water-based Liuzijue exercise - Systemic Lupus Erthematosus | Not applicable | Completed | MTI University | 130 | 2025-08-09 | 2025-12-02 |
| Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases anti-CD19 CAR T cell therapy - Systemic Lupus Erthematosus, Systemic Sclerosis (SSc) | Phase 1 / Phase 2 | Recruiting | Peking University Third Hospital | 9 | 2025-07-01 | 2026-09-22 |
| Mass Spectrometry-based Immune Profiling in Autoimmune Diseases Systemic Lupus Erthematosus, Sjogren's Syndrome | Enrolling by invitation | Peking University People's Hospital | 500 | 2025-05-25 | 2026-08-26 | |
| Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus Serum FGF21 measurement by Enzyme- linked immunosorbent assay (ELISA) - Systemic Lupus Erthematosus | Not yet recruiting | Assiut University | 95 | 2025-05-01 | 2025-02-25 | |
| Cardiovascular Risk in Children With Chronic Conditions Study Kidney Transplant, Familial Hypercholesterolaemia | Recruiting | Semmelweis University | 300 | 2025-04-01 | 2025-08-08 | |
| Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus BCD-256, Divozilimab - Systemic Lupus Erthematosus | Phase 1 | Recruiting | Biocad | 135 | 2025-03-27 | 2025-08-22 |
| Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease anti-CD19/BCMA CAR NK cells (KN5601) - Autoimmune Diseases, Systemic Lupus Erthematosus | Early Phase 1 | Recruiting | The Children's Hospital of Zhejiang University School of Medicine | 36 | 2025-01-30 | 2025-12-01 |
| UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients Physical examination, Electrocardiogram, SF-36 questionnaire - SLE, Lupus | Phase 1 | Recruiting | LiveKidney.Bio | 10 | 2025-01-07 | 2025-09-11 |
| COVID-19 Booster and IIV Schedule in Immunocompromised Hosts Inactivated influenza vaccine (IIV) at baseline, COVID-19 Vaccines at a 3-month interval, Inactivated influenza vaccine at Month 1 - COVID 19, Influenza | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 660 | 2024-11-20 | 2026-10-26 |
| Fatigue in Systemic Lupus Erythematosus Fatigue, Systemic Lupus Erthematosus | Completed | Pamukkale University | 39 | 2024-10-02 | 2024-12-17 | |
| Rare AutoImmune SElf-management Programme Development Non-interventional study - Systemic Lupus Erthematosus, Systemic Vasculitis | Recruiting | University of the West of England | 360 | 2024-10-01 | 2024-10-15 | |
| Bone Mineral Density in Patients With Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria Systemic Lupus Erthematosus | Unknown | Assiut University | 78 | 2024-10-01 | 2024-09-19 | |
| Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity colour doppler of the renal artery and measurement of resistive index - Systemic Lupus Erthematosus, Lupus Glomerulonephritis | Not applicable | Completed | Kasr El Aini Hospital | 75 | 2022-09-03 | 2025-01-03 |
Showing 20 of 22. Sign in to see all of them.
Lupus Erythematosus, Systemic (4) · Scleroderma, Systemic (4) · Sjogren's Syndrome (4) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3) · Fatigue (3) · Myositis (3) · Arthritis, Rheumatoid (2) · Autoimmune Diseases (2) · Inflammatory Bowel Diseases (2) · Neoplasms (2) · Antiphospholipid Syndrome (1) · Aortic Coarctation (1) · Aortic Valve Stenosis (1) · Arthritis, Gouty (1) · Arthritis, Psoriatic (1)
Immune System Diseases (12) · Skin and Connective Tissue Diseases (11) · Autoimmune Diseases (10) · Connective Tissue Diseases (10) · Musculoskeletal Diseases (7) · Arthritis (6) · Joint Diseases (6) · Rheumatic Diseases (6) · Cardiovascular Diseases (5) · Skin Diseases (5) · Vascular Diseases (5) · Arthritis, Rheumatoid (4) · Dry Eye Syndromes (4) · Eye Diseases (4) · Lacrimal Apparatus Diseases (4)
Electrocardiography (1) · Omalizumab (1) · Physical Examination (1) · Prednisone (1) · Pregnancy Tests (1) · Urinalysis (1) · ivarmacitinib (1)
Assiut University (2) · Peking University Third Hospital (2) · Biocad (1) · Cairo University (1) · Chinese SLE Treatment And Research Group (1) · Climb Bio, Inc. (1) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. (1) · Kasr El Aini Hospital (1) · LiveKidney.Bio (1) · MTI University (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Pamukkale University (1) · Peking University People's Hospital (1)
China (6) · Egypt (4) · United States (4) · Canada (1) · Hungary (1) · Russia (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Ali MA Ismail, lecturer (1) · Arina V Zinkina-Orikhan, PhD (1) · Eisa Mohammed Hegazy, Professor (1) · Joanna Robson (1) · Jose E Rubio, MD (1) · Miroslav Backonja, M.D. (1) · Mohammed Hosny Hassan, Professor (1) · Sarfaraz A Hasni, M.D. (1) · Tamas Kiss, MD, PhD (1)
PMID 16142864, PMID 16987829, PMID 17471524, PMID 20360188, PMID 21109517, PMID 25479696, PMID 30597768, PMID 31385462, PMID 32479157, PMID 34133081, PMID 36241363
2025 (1)